TMCnet News
Rising Rates of Diabetes Will Sway the Global Glycated Hemoglobin Testing Market through 2019: TechNavioThe Global Glycated Hemoglobin Testing Market is expected to grow at a CAGR of 10.22 percent from 2014-2019, as diabetes increasingly becomes a worldwide issue, says research firm TechNavio. About the Report According to the latest report by TechNavio, diabetes, which has no concrete cure, is estimated to affect more than 347 million people worldwide. The disease was responsible for millions of deaths last year, and is projected to be the seventh leading cause of death by 2030. "The prevalence of diabetes is on the rise because of an increase in the aging population, sedentary lifestyles, increasing obesity and inappropriate dietary habits. These factors are expected to influence the Global Glycated Hemoglobin Testing Market during the forecast period," says Faisal Ghaus, Vice President of TechNavio. The new TechNavio report also draws attention to delays in the clinical decision-making process, which can lead to delays in treatment and result in serious medical complications. Because of this, there has been increasing adoption of POC HbA1c diagnostic testing, which provides rapid results and helps quickly influencetreatment decisions. "Physicians and patients are increasingly opting for POC HbA1c testing methods, as they are easy to handle, and provide rapid results," says Ghaus. Key Information Covered in the Report:
TechNavio currently has more than 3000 market research reports on a huge range of topics, including 50+ reports on the testing market:
If you are interested in more information, please contact our media team at [email protected].
|
